Clinical Study Report and Individual Participant Data Transparency for US Food and Drug Administration-Approved Anticancer Drugs: A Call for Systematic Data Availability.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38917375.
- Also identified by DOI 10.1200/JCO.24.00539.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Unlocking the full potential of clinical trials through comprehensive CSR and IPD sharing can revolutionize cancer care, enhance safety evaluations, and reduce bias in systematic reviews. It is time for all stakeholders to embrace transparency and advance patient-centered outcomes.
Medical subject headings
- United States Food and Drug Administration
- Antineoplastic Agents
- Drug Approval